These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6619039)

  • 21. Comparison of oral penicillinase-resistant penicillins: contrasts between agents and assays.
    Bass JW; Bruhn FW; Merritt WT; Suttle DE; Jirka JH; Mesrobian RB; Berkenbaugh JT
    South Med J; 1982 Apr; 75(4):408-10. PubMed ID: 7041278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin.
    Marcy SM; Klein JO
    Med Clin North Am; 1970 Sep; 54(5):1127-43. PubMed ID: 4919148
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of saturable clearance during high-dose mezlocillin therapy.
    Drusano GL; Forrest A; Fiore D; Auger F; Caplan ES
    Antimicrob Agents Chemother; 1984 Nov; 26(5):686-8. PubMed ID: 6517555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mezlocillin pharmacokinetics in patients with normal and impaired renal functions.
    Bergan T; Brodwall EK; Wiik-Larsen E
    Antimicrob Agents Chemother; 1979 Nov; 16(5):651-4. PubMed ID: 526008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic concentrations in blood and tissue. Intraoperative ischemia as a model for the determination of tissue concentrations using mezlocillin and oxacillin as examples.
    Adam D; Wilhelm K; Chyský V
    Arzneimittelforschung; 1981; 31(11):1972-6. PubMed ID: 6459100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of sulfaethidole on the human pharmacokinetics of dicloxacillin.
    DeSante KA; Dittert LW; Stavchansky S; Doluisio JT
    J Clin Pharmacol; 1980; 20(8-9):534-42. PubMed ID: 6893599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of mezlocillin during haemodialysis.
    Thorsteinsson SB; Steingrimsson O; Asmundsson P; Bergan T
    Scand J Infect Dis Suppl; 1981; 29():59-63. PubMed ID: 6458883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic concentrations in wound secretions and bone during the simultaneous administration of mezlocillin and oxacillin].
    Wewalka G; Endler M; Kraft A
    Infection; 1982; 10 Suppl 3():S213-6. PubMed ID: 6218117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent pharmacokinetics of mezlocillin in subjects with normal and impaired renal function.
    Mangione A; Janicke DM; Boudinot FD; Schultz RM; Jusko WJ
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():81-5. PubMed ID: 6210686
    [No Abstract]   [Full Text] [Related]  

  • 31. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fixed combination mezlocillin/oxacillin injected intramuscularly. Comparative study of local tolerability compared with ampicillin and determination of effectiveness and tolerability in the treatment of surgical and urinary tract infections.
    Belli L; Freylejer A; Ginesín LM; Ríos JF; Gandolfo S
    Arzneimittelforschung; 1980; 30(10):1804-7. PubMed ID: 6449205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonlinear mezlocillin kinetics due to dose-dependent metabolism.
    Gundert-Remy U; Hildebrandt R; Stiehl A; Weber E
    Clin Pharmacol Ther; 1983 May; 33(5):656-62. PubMed ID: 6220858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mezlocillin and oxacillin concentrations in the bile of the choledochus].
    Brandstätter G; Kratochvil P; Adam D; Chyský V
    Infection; 1982; 10 Suppl 3():S209-12. PubMed ID: 6218116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function.
    Kampf D; Borner K; Möller M; Kessel M
    Clin Pharmacol Ther; 1984 Feb; 35(2):214-20. PubMed ID: 6319069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mezlocillin kinetics in hepatic insufficiency.
    Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
    Clin Pharmacol Ther; 1983 Jan; 33(1):73-6. PubMed ID: 6217018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin.
    Sutherland R; Croydon EA; Rolinson GN
    Br Med J; 1970 Nov; 4(5733):455-60. PubMed ID: 5481218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dicloxacillin: its chemotherapeutic action and experimental kinetic characteristics].
    Lobuseva AN; Vasil'ev VK; Berezina EK; Speranskaia ON; Fomina IP
    Antibiotiki; 1975 Jun; 20(7):640-6. PubMed ID: 1225214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mezlocillin disposition in chronic hemodialysis patients.
    Janicke DM; Mangione A; Schultz RW; Jusko WJ
    Antimicrob Agents Chemother; 1981 Nov; 20(5):590-4. PubMed ID: 6459760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetics of two multiple-dose mezlocillin regimens in normal volunteers.
    Colaizzi PA; Coniglio AA; Poynor WJ; Vishniavsky N; Karnes HT; Polk RE
    Antimicrob Agents Chemother; 1986 Nov; 30(5):675-8. PubMed ID: 3800343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.